The downgrade from Outperform to Market Perform by a notable analyst could lead to a negative perception among investors, potentially impacting the stock's short-term performance negatively. The maintained price target of $4 suggests that the analyst sees limited upside potential from current levels, reinforcing the neutral to slightly negative outlook.